Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Carolyn Lefkowits to Adult

This is a "connection" page, showing publications Carolyn Lefkowits has written about Adult.

 
Connection Strength
 
 
 
0.236
 
  1. Rauh LA, Sullivan MW, Camacho F, Janke MJ, Duska LR, Chandler C, Sukumvanich P, Courtney-Brooks M, Lefkowits C. Validation of the surprise question in gynecologic oncology: A one-question screen to promote palliative care integration and advance care planning. Gynecol Oncol. 2020 06; 157(3):754-758.
    View in: PubMed
    Score: 0.039
  2. Ross ME, Wheeler LJ, Flink DM, Lefkowits C. Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period. Int J Gynecol Cancer. 2019 11; 29(9):1411-1416.
    View in: PubMed
    Score: 0.038
  3. Ward K, Ramzan A, Sheeder J, Fischer S, Lefkowits C. Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors. Int J Gynecol Cancer. 2019 09; 29(7):1105-1109.
    View in: PubMed
    Score: 0.038
  4. Lefkowits C, Bevis K, Carey EC, Sheeder J, Arnold RM, Podgurski L. Gynecologic oncology providers endorse practice-changing impact of communication skills training. Gynecol Oncol. 2019 06; 153(3):633-638.
    View in: PubMed
    Score: 0.037
  5. Lefkowits C, Teuteberg W, Courtney-Brooks M, Sukumvanich P, Ruskin R, Kelley JL. Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. Gynecol Oncol. 2015 Mar; 136(3):424-8.
    View in: PubMed
    Score: 0.027
  6. Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JA. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78.
    View in: PubMed
    Score: 0.011
  7. Nitecki R, Fu S, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Rauh-Hain JA. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol. 2021 01; 160(1):199-205.
    View in: PubMed
    Score: 0.010
  8. Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, Cheng G, Ramzan AA, Wheeler LJ, Corr BR, Lefkowits C, Sheeder J, Matsuo K, Flink D. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e207410.
    View in: PubMed
    Score: 0.010
  9. Moroney MR, Davies KD, Wilberger AC, Sheeder J, Post MD, Berning AA, Fisher C, Lefkowits C, Guntupalli SR, Behbakht K, Corr BR. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers. Gynecol Oncol. 2019 06; 153(3):517-520.
    View in: PubMed
    Score: 0.009
  10. Zakem SJ, Robin TP, Smith DE, Amini A, Stokes WA, Lefkowits C, Fisher CM. Evolving trends in the management of high-intermediate risk endometrial cancer in the United States. Gynecol Oncol. 2019 03; 152(3):522-527.
    View in: PubMed
    Score: 0.009
  11. Hay CM, Courtney-Brooks M, Lefkowits C, Hagan TL, Edwards RP, Donovan HS. Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important? Gynecol Oncol. 2016 Nov; 143(2):367-370.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)